Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University Ghent |
---|---|
Information provided by: | University Ghent |
ClinicalTrials.gov Identifier: | NCT00262418 |
Comparison of the efficacy and safety of a single administration of ivermectin to a single administration of permethrin for the treatment of scabies
Condition | Intervention | Phase |
---|---|---|
Scabies |
Drug: Administration of ivermectin or permethrin |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Randomised, Double Blind, Double Dummy Study to Compare the Efficacy and Safety of a Single Administration of Ivermectin to a Single Administration of Permethrin for the Treatment of Scabies |
Enrollment: | 160 |
Study Start Date: | July 2004 |
Study Completion Date: | May 2005 |
Administration of ivermectin or permethrin on day0 Clinical examination and pictures on day0, day14 and day28 Blood sample on day0 VAS for pruritus, DLQI and SF-36 on day0, day14 and day28
Ages Eligible for Study: | 5 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
At least one of the following inclusion criteria:
At least two of the three following inclusion criteria:
Exclusion Criteria:
Study ID Numbers: | 2004/212 |
Study First Received: | December 4, 2005 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00262418 |
Health Authority: | Belgium: Institutional Review Board |
Skin Diseases, Infectious Skin Diseases Ivermectin |
Scabies Permethrin Parasitic Diseases |
Anti-Infective Agents Ectoparasitic Infestations Antiparasitic Agents Molecular Mechanisms of Pharmacological Action Skin Diseases, Parasitic |
Therapeutic Uses Enzyme Inhibitors Pharmacologic Actions Mite Infestations |